Literature DB >> 10605411

Extension of extramammary Paget disease of the vulva to the cervix.

J Lloyd1, D J Evans, A M Flanagan.   

Abstract

Extramammary Paget disease of the vulva was found in association with vulval adenocarcinoma in an elderly woman who also had a uterine prolapse. The characteristic histological appearances of extramammary Paget disease were masked by striking reactive changes in the squamous epithelium. Primary excision of both the intraepithelial and invasive disease appeared complete. However, a subsequent hysterectomy with repair of the prolapse revealed extramammary Paget disease in the upper vaginal mucosa and cervix, a finding which is very rarely described. Pathogenesis and diagnosis of extramammary Paget disease is discussed, with differential diagnosis and reference to immunohistochemical methods.

Entities:  

Mesh:

Year:  1999        PMID: 10605411      PMCID: PMC501500          DOI: 10.1136/jcp.52.7.538

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  9 in total

1.  Paget's disease and melanoma of the vulva. Use of a panel of monoclonal antibodies to identify cell type and to microscopically define adequacy of surgical margins.

Authors:  C E Bacchi; G A Goldfogel; B E Greer; A M Gown
Journal:  Gynecol Oncol       Date:  1992-08       Impact factor: 5.482

Review 2.  Invasive adenocarcinoma arising in extramammary Paget's disease of the vulva.

Authors:  A T Evans; P Neven
Journal:  Histopathology       Date:  1991-04       Impact factor: 5.087

3.  Extramammary Paget's disease with diffuse involvement of the lower female genito-urinary system.

Authors:  J P Geisler; R W Gates; W Shirrell; S M Parker; C D Maloney; M C Wiemann; H E Geisler
Journal:  Int J Gynecol Cancer       Date:  1997-01       Impact factor: 3.437

4.  Extramammary Paget's disease. A critical reexamination.

Authors:  R E Jones; C Austin; A B Ackerman
Journal:  Am J Dermatopathol       Date:  1979       Impact factor: 1.533

5.  Paget's disease with extensive involvement of the female genital tract initially detected by cervical cytosmear.

Authors:  T J Costello; H H Wang; S J Schnitt; R Ritter; D A Antonioli
Journal:  Arch Pathol Lab Med       Date:  1988-09       Impact factor: 5.534

6.  Paget's disease of the vulva.

Authors:  J P Curtin; S C Rubin; W B Jones; W J Hoskins; J L Lewis
Journal:  Gynecol Oncol       Date:  1990-12       Impact factor: 5.482

7.  Vulvar Paget's disease: a clinicopathologic and immunohistochemical study of 19 cases.

Authors:  J R Goldblum; W R Hart
Journal:  Am J Surg Pathol       Date:  1997-10       Impact factor: 6.394

Review 8.  [Paget disease of the vulva. 36 cases].

Authors:  V Molinie; B J Paniel; M Lessana-Leibowitch; M Moyal-Barracco; M Pelisse; J P Escande
Journal:  Ann Dermatol Venereol       Date:  1993       Impact factor: 0.777

9.  [Extramammary Paget's disease with internal malignancies].

Authors:  Y Hayashibara; S Ikeda
Journal:  Gan To Kagaku Ryoho       Date:  1988-04
  9 in total
  4 in total

Review 1.  Mammary and extramammary Paget's disease.

Authors:  J Lloyd; A M Flanagan
Journal:  J Clin Pathol       Date:  2000-10       Impact factor: 3.411

2.  Concordance of the HER2 protein and gene status between primary and corresponding lymph node metastatic sites of extramammary Paget disease.

Authors:  Ryota Tanaka; Yuko Sasajima; Hitoshi Tsuda; Kenjiro Namikawa; Akira Takahashi; Arata Tsutsumida; Yasuhiro Fujisawa; Manabu Fujimoto; Naoya Yamazaki
Journal:  Clin Exp Metastasis       Date:  2016-06-11       Impact factor: 5.150

3.  Invasive cervical adenocarcinoma arising from extension of recurrent vulval Paget's disease.

Authors:  Liesel Elisabeth Hardy; Lachlan Baxter; King Wan; Chloe Ayres
Journal:  BMJ Case Rep       Date:  2020-06-11

4.  Chemokine Receptors CXCR4 and CXCR7 are Associated with Tumor Aggressiveness and Prognosis in Extramammary Paget Disease.

Authors:  Kun Chang; Gao-Xiang Li; Yun-Yi Kong; Xu-Xia Shen; Yuan-Yuan Qu; Zhong-Wei Jia; Yue Wang; Bo Dai; Ding-Wei Ye
Journal:  J Cancer       Date:  2017-08-02       Impact factor: 4.207

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.